Skip to main navigation Skip to search Skip to main content

Nanotechnology-based advancements in NF-κB pathway inhibition for the treatment of inflammatory lung diseases

  • Asif Ahmad Bhat
  • , Gaurav Gupta
  • , Santosh Kumar Singh
  • , Hemant K.S. Yadav
  • , Mahendra Saini
  • , Roshan Salfi
  • , Sachin Kumar Singh
  • , Kamal Dua
  • Suresh Gyan Vihar University
  • Saveetha Institute of Medical and Technical Sciences (Deemed to be University)
  • Uttaranchal University
  • Osmania University
  • Yenepoya Pharmacy College & Research Centre
  • Lovely Professional University
  • University of Technology Sydney

Research output: Contribution to journalComment/debate

42 Scopus citations
Original languageEnglish
Pages (from-to)2209-2213
Number of pages5
JournalNanomedicine
Volume17
Issue number30
DOIs
StatePublished - 1 Dec 2022
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • COPD
  • NF-κB pathway
  • asthma
  • lung
  • nanotechnology

Cite this